BRCA. It's not just about breast cancer anymore.

Monday, November 4 at 3:00 pm ET

Register to Attend Online (Free)

You'll be able to join live while we record.
You are all registered!

You will get an email with all the information you'll need to connect.

We look forward to seeing you!
Oops! Something went wrong while submitting the form.

In this webinar, Jeremy and Jason Sager, MD, discuss the BRCA gene, its role in DNA repair, and its association with increased cancer risk. They explore the differences between BRCA1 and BRCA2, the prevalence of mutations in various populations, and guidelines for genetic testing. The conversation also covers risk management strategies for BRCA carriers, including enhanced surveillance and preventive surgeries, as well as considerations for family planning. This conversation delves into the complexities of BRCA mutations, their implications for cancer risk, and the various preventative measures and treatments available. The discussion covers hormone therapy during menopause, surgical options for risk reduction, lifestyle choices for cancer prevention, and innovative treatments for BRCA-driven cancers. The importance of genetic counseling and the evolving landscape of cancer treatment are emphasized, providing valuable insights for individuals navigating these challenges.

As Dr. Sager mentions in the video, the United States Preventive Services Task Force has made recommendations about who should be offered genetic testing for BRCA mutations.

‍

Testing Recommendations

If you fit any of these requirements, you should discuss being tested for BRCA with your doctor. You do not need to meet these guidelines to request a test.

For All Women (see below for Ashkenazi Jewish women)
2 first-degree relatives with breast cancer, 1 of whom was diagnosed at age 50 or younger
A combination of 3 or more first- or second-degree relatives with breast cancer regardless of age at diagnosis
A combination of both breast and ovarian cancer among first- and second-degree relatives
A first-degree relative with bilateral breast cancer
A combination of 2 or more first- or second-degree relatives with ovarian cancer, regardless of age at diagnosis
A first- or second-degree relative with both breast and ovarian cancer at any age
History of breast cancer in a male relative
For women of Ashkenazi Jewish descent:
Any first-degree relative (or 2 second-degree relatives on the same side of the family) with breast or ovarian cancer
* These recommendations do not apply to women with a family history of breast or ovarian cancer that includes a relative with a known deleterious BRCA mutation.

‍

Keywords
BRCA, cancer risk, genetic testing, BRCA1, BRCA2, hereditary cancer, preventive surgery, cancer awareness, genetic mutations, health education, BRCA, cancer prevention, hormone therapy, ovarian cancer, breast cancer, risk reduction, lifestyle choices, innovative treatments, menopause, genetic counseling

Key Takeaways

  • ‍‍BRCA is a key gene involved in DNA repair.
  • Mutations in BRCA increase the risk of certain cancers.
  • BRCA1 and BRCA2 have different implications for cancer risk.
  • Testing for BRCA mutations is recommended for high-risk individuals.
  • Enhanced surveillance can significantly improve early detection of cancer.
  • Preventive surgeries can reduce cancer risk by up to 95%.
  • Family planning is still feasible for BRCA-positive individuals.
  • Awareness of BRCA mutations is crucial for proactive health management.
  • Genetic counseling is important for understanding test results.
  • Regular screenings are essential for managing cancer risk. Hormone therapy can increase breast cancer risk for BRCA carriers.
  • Tamoxifen reduces breast cancer risk by about 30%.
  • Ovarian removal surgery can significantly lower cancer risk.
  • Maintaining a healthy lifestyle is crucial for cancer prevention.
  • PARP inhibitors are effective for BRCA-related cancers.
  • New treatments for ovarian cancer are on the horizon.
  • Understanding the origin of ovarian cancer is essential for treatment.
  • Next-gen tumor sequencing helps tailor cancer therapies.
  • BRCA1 and BRCA2 mutations have different cancer risk profiles.
  • Genetic counseling is vital for those with BRCA mutations.

‍

Sound Bites:
"What is BRCA?"
"BRCA1 and BRCA2 are different but similar."
"Who should get tested for BRCA?"
"Testing for BRCA is a one-time event."
"Hormones are connected to breast cancer."
"Ovarian removal can reduce cancer risk."
"Healthy lifestyle is always recommended."
"PARP inhibitors can add years to life."
"New drugs are coming down the pike."
"Next-gen tumor sequencing is crucial."
"Seek a genetic counselor for BRCA guidance."

Chapters
00:00 - Understanding BRCA: The Basics
03:00 - The Role of BRCA in Cancer Risk
05:53 - BRCA1 vs BRCA2: Key Differences
09:13 - Prevalence of BRCA Mutations
11:46 - Who Should Get Tested for BRCA?
15:11 - Testing Process and Results
18:06 - Risk Management for BRCA Carriers
21:04 - Preventive Measures: Surveillance and Surgery
23:49 - Family Planning and BRCA Mutations
28:51 - Navigating Menopause and Hormone Therapy Risks
31:30 - Preventative Measures for BRCA Carriers
32:49 - Surgical Options for Risk Reduction
36:28 - Lifestyle Choices and Cancer Prevention
37:34 - Understanding BRCA-Driven Cancers
42:32 - Innovative Treatments for Ovarian Cancer
46:54 - The Evolution of Cancer Treatment
49:51 - The Connection Between Fallopian Tubes and Ovarian Cancer
51:21- Understanding BRCA Variants and Cancer Risks
53:07 - Guidance for BRCA Mutation Carriers
54:43 - Accessing Innovative Cancer Treatments